FENNEC PHARMACEUTICALS INC. — Director's Dealing 2021

Jul 1, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2021-06-29

Reporting Person: Islam Khalid (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-29	Stock Option (right to buy)	$7.52	A	25000	Acquired	2031-06-29	Common Shares (25000)	Direct

Footnotes

F1: On June 29, 2021, Khalid Islam was granted a non-qualified stock option to purchase 25,000 shares of the Issuer's common shares pursuant to the Issuer's Equity Incentive Plan.

F2: The option is 100% vested on the date of grant.